Clayton gave a proffered talk at the Society of Surgical Oncology (SSO) Annual Meeting 2025, sharing his results about detection of cancer in patients who have presented with incidental pancreatic lesions, using a novel blood test.
There is a preprint describing these results, where you can find out more.